As Regenerative Medicine Grows in Japan, Challenges Remain
On November 11, 2021, a global conference on “The Clinical Development and Integration Strategies of Key Manufacturing Process of Regenerative Medicine in Japan” was held. Hosted by the Foundation of Medical Professionals Alliance in Taiwan, the event invited Japanese scholars to share and discuss trends and changes in Japan’s regenerative medicine industry and technology.
Hideyuki Okano, a professor in the Department of Medicine at Keio University and the chairman of the Japan Society for Regenerative Medicine (JSRM), introduced his lab’s work in regenerative medicine and iPS cell therapy.
Hideyuki Okano, a professor in the Department of Medicine at Keio University and the chairman of the Japan Society for Regenerative Medicine (JSRM), introduced his lab’s work in regenerative medicine and iPS cell therapy.
It's free! Log in now to read
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115